We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,081

USPTO Says Overlapping Range In Prior Art Insufficient to Invalidate Method of Treatment Patent
  • Dechert LLP
  • USA
  • April 13 2018

Pharmaceutical patents frequently claim treatment methods that utilize a range of amounts or concentrations for the active ingredient or excipients

Rituxan Patent Spared by Failure to Establish Product Label as “Printed Publication”
  • Marshall Gerstein & Borun LLP
  • USA
  • March 26 2018

A patent relating to a method of treating rheumatoid arthritis using rituximab recently survived its fourth IPR challenge. Celltrion, Inc. v. Biogen

  • Marshall Gerstein & Borun LLP
  • USA
  • February 21 2018

In re Janssen Biotech, Inc., Appeal 2017-1257 (Fed. Cir. Jan. 23, 2018), is a cautionary tale concerning patents protecting a blockbuster drug

California Passes Two Drug Pricing Transparency Laws
  • Quarles & Brady LLP
  • USA
  • November 20 2017

Last month, California Governor Jerry Brown signed two new bills aimed at curtailing rising prescription drug costs, joining other states like

CMS Releases 2018 MACRA Final Rule
  • Holland & Knight LLP
  • USA
  • November 10 2017

The Centers for Medicare & Medicaid Services (CMS) on Nov. 2, 2017, posted the CY 2018 Quality Payment Program (QPP) Final Rule. CMS finalized

Post-Grant Amendments from Method of Treatment to Swiss-Style - The Singapore Position
  • Mirandah Asia
  • Singapore
  • August 17 2017

In the landmark case of Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd 2017 SGCA 45, the Singapore Court of Appeal explored, inte

Considerations for Developing a Global Patent Term Extension Strategy
  • Sterne Kessler Goldstein & Fox PLLC
  • Global
  • August 15 2017

Many jurisdictions provide for the extension of the term of the patents that cover a regulated product. Patent term extension (PTE) is particularly

Patent Term Extension Considerations for BioPharma Patents
  • Sterne Kessler Goldstein & Fox PLLC
  • USA
  • August 15 2017

Time spent on securing marketing approval for regulated products, such as pharmaceuticals, medical devices and agrochemicals effectively shortens the

China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry
  • Hogan Lovells
  • China
  • August 14 2017

One day later, NDRC made public the full text of its decisions against two local companies for excessive pricing and refusal to supply active

TİTCK Publishes New Guidelines on Stability Testing of Active Ingredients and Final Products
  • Baker McKenzie
  • Turkey
  • July 28 2017

Recent Development The Turkish Medicines and Medical Devices Agency (the "TİTCK") recently published the Guidelines on Stability Testing of Active